Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Payables (2016 - 2025)

Rockwell Medical's Payables history spans 16 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Payables fell 27.86% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, down 27.86%, while the annual FY2025 figure was $2.3 million, 27.86% down from the prior year.
  • Payables reached $2.3 million in Q4 2025 per RMTI's latest filing, up from $2.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $6.7 million in Q2 2023 to a low of $2.0 million in Q3 2025.
  • Average Payables over 5 years is $4.0 million, with a median of $4.2 million recorded in 2021.
  • Peak YoY movement for Payables: soared 49.63% in 2023, then tumbled 59.5% in 2025.
  • A 5-year view of Payables shows it stood at $4.2 million in 2021, then rose by 9.1% to $4.6 million in 2022, then grew by 4.48% to $4.8 million in 2023, then plummeted by 34.1% to $3.1 million in 2024, then fell by 27.86% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Payables are $2.3 million (Q4 2025), $2.0 million (Q3 2025), and $2.2 million (Q2 2025).